← FDA Drug Approvals (Drugs@FDA)
DOVATO
NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2019-04-08
Drug application
- FDA Application #
NDA211994- Application type
- New Drug Application
- Brand name
- DOVATO
- Generic name
- DOLUTEGRAVIR SODIUM AND LAMIVUDINE
- Active ingredients
- DOLUTEGRAVIR SODIUM; LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- VIIV HLTHCARE
- Manufacturer
- ViiV Healthcare Company
- First approval
- 2019-04-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown